GLP-1 weight loss drugs are getting a major upgrade
Digest more
The U.S. Food and Drug Administration has approved Omeros' drug for a dangerous transplant complication in adults and children two years and older, marking the first treatment to be greenlit for the condition,
The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss medications in the U.S.
Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.
Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through the courts. Thousands of
Below, STAT previews the three key questions that could define a potentially busy year in the worlds of substance use and behavioral health. On the issue of marijuana, the Trump administration has its work cut out for it in 2026.